These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 21859344)

  • 21. The genetics of type I interferon in systemic lupus erythematosus.
    Bronson PG; Chaivorapol C; Ortmann W; Behrens TW; Graham RR
    Curr Opin Immunol; 2012 Oct; 24(5):530-7. PubMed ID: 22889593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitor of IkappaB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells.
    Miyamoto R; Ito T; Nomura S; Amakawa R; Amuro H; Katashiba Y; Ogata M; Murakami N; Shimamoto K; Yamazaki C; Hoshino K; Kaisho T; Fukuhara S
    Arthritis Res Ther; 2010; 12(3):R87. PubMed ID: 20470398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type I IFN system in the development and manifestations of SLE.
    Elkon KB; Wiedeman A
    Curr Opin Rheumatol; 2012 Sep; 24(5):499-505. PubMed ID: 22832823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type I interferon in systemic lupus erythematosus.
    Crow MK
    Curr Top Microbiol Immunol; 2007; 316():359-86. PubMed ID: 17969456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.
    Lövgren T; Eloranta ML; Båve U; Alm GV; Rönnblom L
    Arthritis Rheum; 2004 Jun; 50(6):1861-72. PubMed ID: 15188363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new tool for detection of type I interferon activation in systemic lupus erythematosus.
    Kirou KA; Kalliolias GD
    Arthritis Res Ther; 2010; 12(4):138. PubMed ID: 20815919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.
    Chasset F; Ribi C; Trendelenburg M; Huynh-Do U; Roux-Lombard P; Courvoisier DS; Chizzolini C;
    Rheumatology (Oxford); 2020 Nov; 59(11):3468-3478. PubMed ID: 32375176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin.
    Lambers WM; de Leeuw K; Doornbos-van der Meer B; Diercks GFH; Bootsma H; Westra J
    Arthritis Res Ther; 2019 Dec; 21(1):260. PubMed ID: 31791398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The regional function of cGAS/STING signal in multiple organs: One of culprit behind systemic lupus erythematosus?
    Ding L; Dong G; Zhang D; Ni Y; Hou Y
    Med Hypotheses; 2015 Dec; 85(6):846-9. PubMed ID: 26464144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus.
    Mangini AJ; Lafyatis R; Van Seventer JM
    Ann N Y Acad Sci; 2007 Jun; 1108():11-23. PubMed ID: 17893966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prion-like Aggregation of Mitochondrial Antiviral Signaling Protein in Lupus Patients Is Associated With Increased Levels of Type I Interferon.
    Shao WH; Shu DH; Zhen Y; Hilliard B; Priest SO; Cesaroni M; Ting JP; Cohen PL
    Arthritis Rheumatol; 2016 Nov; 68(11):2697-2707. PubMed ID: 27110677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of genetic variation near interferon-kappa in systemic lupus erythematosus.
    Harley IT; Niewold TB; Stormont RM; Kaufman KM; Glenn SB; Franek BS; Kelly JA; Kilpatrick JR; Hutchings D; Divers J; Bruner GR; Edberg JC; McGwin G; Petri MA; Ramsey-Goldman R; Reveille JD; Vilá-Pérez LM; Merrill JT; Gilkeson GS; Vyse TJ; Alarcón-Riquelme ME; Cho SK; Jacob CO; Alarcón GS; Moser KL; Gaffney PM; Kimberly RP; Bae SC; Langefeld CD; Harley JB; Guthridge JM; James JA
    J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20706608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
    Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
    Front Immunol; 2021; 12():653989. PubMed ID: 33868295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus.
    Casey KA; Smith MA; Sinibaldi D; Seto NL; Playford MP; Wang X; Carlucci PM; Wang L; Illei G; Yu B; Wang S; Remaley AT; Mehta NN; Kaplan MJ; White WI
    Arthritis Rheumatol; 2021 Mar; 73(3):459-471. PubMed ID: 32909675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in understanding the role of type I interferons in systemic lupus erythematosus.
    Crow MK
    Curr Opin Rheumatol; 2014 Sep; 26(5):467-74. PubMed ID: 25010440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coordination of retrotransposons and type I interferon with distinct interferon pathways in dermatomyositis, systemic lupus erythematosus and autoimmune blistering disease.
    Kuriyama Y; Shimizu A; Kanai S; Oikawa D; Motegi SI; Tokunaga F; Ishikawa O
    Sci Rep; 2021 Nov; 11(1):23146. PubMed ID: 34848794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-interferon alpha treatment in SLE.
    Kirou KA; Gkrouzman E
    Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.